By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Where Your Profits Grow Sky High.

SGS Institute Fresenius opens a diagnostics laboratory in Tyrol

woman wearing face mask © Fresenius

The company SGS Institut Fresenius Diagnostiklabor GmbH was established in collaboration with the pathology laboratory Dr. Obrist – Dr. Brunhuber. The new laboratory focuses on analytics for personalised medicine from liquid biopsy (i.e., blood). Personalised medicine is mainly used in the initial diagnosis of tumour and cancer diseases and for assessing the course of treatment. Moreover, the laboratory also offers SARS-CoV-2-PCR tests analytics, especially for companies which want to regularly check their workforce until the pandemic has been contained as well as for event organisers aiming to secure their events.

The SGS Institute Fresenius ranks among the leading providers of non-medical laboratory analysis in Europe. It is part of the SGS Group, the world's leading company in examination, testing, verification and certification. Founded in 1878 and headquartered in Geneva, SGS has more than 89,000 employees and an international network of more than 2,600 branches and laboratories across the globe.

Continue reading and learn more about the successes in cancer research at the University of Innsbruck!

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin



Meet us at events, seminars and trade shows - worldwide.

  • Austria – Carinthia your ICT Hub in the Heart of Europe

    14.04.2021/ 02.30 pm (India Time) , Online Conference

Austria Map

Find the perfect location for your company

Vienna is a beautiful city and a natural place to be for Trask. We are happy that we can introduce our great technology expertise together with revolutionary ready-to-use solutions to Austrian banks. And thanks to the cooperation with ABA everything is a bit easier.

Daniel Pecina, CEO Trask Austria GmbH

trask logo
More testimonials

news from the business location Austria

Austrians conduct research in New York on low-priced vaccine

Two Austrians are conducting research in New York on a vaccine against the coronavirus which is designed to be available at a particularly low price and also be easy to dispense.

Support measures for companies affected by COVID-19

To stimulate the economy, either new programs may be established as a result of the draft law or existing support programs (e.g. aws, ÖHT) will be expanded. All measures introduced are intended to be applicable immediately and will be in force until the end of 2020. The measures currently introduced include the following areas:

More news All blog posts